Effect of Apolipoprotein E Phenotype on Cerebrospinal Fluid Levels of Tau in Patients With Dementia of Alzheimer Type.

Japanese Journal of Geriatrics - Japan
doi 10.3143/geriatrics.33.120
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The Japan Geriatrics Society

Related search

Enzymatic Changes in Cerebrospinal Fluid of Patients With Alzheimer-Type Dementia.

Journal of Clinical Biochemistry and Nutrition
MedicineNutritionClinical BiochemistryDietetics
1993English

Novel Panel of Cerebrospinal Fluid Biomarkers for the Prediction of Progression to Alzheimer Dementia in Patients With Mild Cognitive Impairment

Archives of Neurology
2007English

Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients With Alzheimer’s Disease

Journal of Alzheimer's Disease
GerontologyClinical PsychologyMental HealthPsychiatryGeriatricsMedicineNeuroscience
2017English

GWAS of Cerebrospinal Fluid Tau Levels Identifies Risk Variants for Alzheimer’s Disease

Neuron
Neuroscience
2013English

Searching for Novel Cerebrospinal Fluid Biomarkers of Tau Pathology in Frontotemporal Dementia: An Elusive Quest

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2019English

Elevated Levels of NLRP3 in Cerebrospinal Fluid of Patients With Autoimmune GFAP Astrocytopathy

Frontiers in Neurology
Neurology
2019English

T-Lymphocyte Interleukin 6 Receptor Binding in Patients With Dementia of Alzheimer Type

Archives of Neurology
1998English

Tau Transgenic Mice as Models for Cerebrospinal Fluid Tau Biomarkers

Journal of Alzheimer's Disease
GerontologyClinical PsychologyMental HealthPsychiatryGeriatricsMedicineNeuroscience
2011English

Negative Cerebrospinal Fluid Reactions in Dementia Paralytica

Sexually Transmitted Infections
DermatologyInfectious Diseases
1945English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy